{
    "code": "02025968",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025968",
    "time": "2020-01-31 03:08:26",
    "許可證字號": "衛署藥輸字第025968號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "112\/04\/08",
    "發證日期": "102\/04\/08",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202596809",
    "中文品名": "艾泌平&quot;艾威群&quot;注射劑2毫克\/毫升",
    "英文品名": "Epirubicin &quot;Alvogen&quot; 2mg\/ml Injection solution",
    "適應症": "乳腺癌、惡性淋巴瘤、軟組織肉瘤、胃癌、肺癌、卵巢瘤。",
    "劑型": "270注射劑",
    "包裝": "5毫升、25毫升玻璃小瓶裝 100支以下盒裝",
    "": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "-->\r\n                    \r\n                        \r\n                            標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入 1Q不得輸入 24監視期滿學名藥",
        "申請商名稱": "0901301200  美時化學製藥股份有限公司",
        "申請商地址": "台北市信義區松仁路277號17樓",
        "主製造廠": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1012000910",
            "成分名稱": "EPIRUBICIN HCL",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "PIL_6071_Round_4-107-05-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025968&Seq=005&Type=9"
        },
        {
            "title": "2016-08-22 epirubicin labeling-105-09-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025968&Seq=004&Type=9"
        },
        {
            "title": "Label_3118_reg_4-107-05-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025968&Seq=011&Type=8"
        },
        {
            "title": "Carton_6070_Round_4-107-05-15(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025968&Seq=010&Type=8"
        }
    ]
}